About BioDerm
BioDerm is a Healthcare company based in Largo (United States) founded in 1991, and was acquired by Mountaingate in January 2021. Hydrocolloid products are developed for urinary management and skin protection. The company has 73 employees. Its chief executive, as recorded, is Gary Damkoehler. BioDerm offers products and services including Silverlon Dressings, Anasept Cleanser, and Men’s Liberty Device. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its competitors include NanoVibronix and Aurie; 2 of its 2 listed competitors have raised funding.
Company details
BioDerm was founded in 1991 and is headquartered in Largo, United States. Proprietary hydrocolloid-based medical devices are developed for urinary management, security, infection control, and skin protection within the healthcare sector. Key offerings include Mens Liberty, a male external catheter suited for community-dwelling men, and Safe n Dry, intended for institutional and hospital settings. Leadership is provided by Chairman and CEO Gary Damkoehler.
- Headquarters Largo, United States
- Employees 73
- Stage Acquired
- SectorsHealthcare
- Website bioderminc.com
- Social LinkedIn X Facebook
- Acquired by Mountaingate (Jan 2021)
- InvestorsAbacus Finance
& 1 more
- Employee Count73
- Acquired byMountaingate
(Jan 2021)
Products & Services of BioDerm
BioDerm offers a comprehensive portfolio of products and services, including Silverlon Dressings, Anasept Cleanser, and Men’s Liberty Device.
Antimicrobial dressings for preventing infections in wounds
Cleanser that removes microorganisms from wound beds
External catheter for managing urinary incontinence
Funding Insights of BioDerm
- Total Rounds 2
- First Round $603,850
(Jun 2011)
- Investors Count 1
All 2 funding rounds of BioDerm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | Series A | – | Abacus Finance Group | – | |
| Jun 2011 | $603,850 | Unspecified | – | – | – |
2 investors in total: 2 institutional.
Investors in BioDerm
BioDerm has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Abacus Finance and Mountaingate Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Abacus Finance is engaged in providing tailored credit solutions to lower-middle market companies. | abacusfinance.com | New York, United States | ||
Mountaingate Capital is engaged in private equity investments for growth-focused companies. | mountaingate.com | Denver, United States |
Investor details for BioDerm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioDerm
22 people are tracked at BioDerm (13 in leadership, 9 in team); the tracked headcount is 73.
| Name | Role | Group |
|---|---|---|
Gary Damkoehler | Chairman & CEO | Leadership |
Shawn Stone | Vice President Operations | Leadership |
Colleen Kennedy | VP D2c Sales & Marketing | Leadership |
Nehal Acharya | VP Of Finance And Business Development | Leadership |
Michael Foley | Director Of Engineering | Leadership |
David Moyer | Vice President Of Sales | Leadership |
Raul Brizuela | President & CEO | Leadership |
Christopher Murray | Chief Commercial Officer | Leadership |
Jim Fitzgerald | Vice President Of Quality And Regulatory Affairs | Leadership |
Joe Caldwell | Vice President, Sales And Marketing | Leadership |
Andrew Muser | VP Of Research And Development | Leadership |
Chris Isbell | Surgical Sales Director - West | Leadership |
Kartik Patel | Senior Director, Quality Assurance And Regulatory Affairs | Leadership |
Kelly Raczniak | Regional Sales Manager | Team |
Oscar Franco | Quality, Regulatory & Validation Engineer | Team |
Michael Waldron | Regional Sales Manager | Team |
Samantha Shelden Elliott | Regional Sales Manager | Team |
Paul Soule | Regional Sales Manager | Team |
Jeremy Merriman | Regional Sales Manager | Team |
Adam Mott | Plant Manager | Team |
2 more people are available in the full profile.
Complete people profiles for BioDerm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioDerm
4 dated milestones of BioDerm across 30 years, from founding to its latest funding, stage changes and deals.
- Founded BioDerm is founded.
- Funding First funding round of $604K.
- Exit Acquired by Mountaingate.
- Funding Latest funding round, Series A,.
Competitors of BioDerm
BioDerm has 2 listed competitors in our database, 2 of them funded. They include NanoVibronix and Aurie.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanovibronix.com | 2003 | Elmsford, United States | $10.89M | 10 | Provider of ultrasound therapy devices for multiple health purposes | |
| livewithaurie.com | 2017 | New York, United States | $12.23M | 4 | Automated reusable self-catheter systems are developed for urinary retention patients. |
Detailed competitors of BioDerm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioDerm
The website of BioDerm (bioderminc.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▼ 45.8% vs previous month
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as BioDerm (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioderm
Complete news archive for BioDerm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioDerm
BioDerm was founded in 1991 and raised its 1st funding round 20 years after it was founded.
BioDerm is headquartered in Largo, United States. It is registered at Largo, Florida, United States.
Gary Damkoehler is the CEO of BioDerm, as recorded in our data.
BioDerm has 73 employees.
BioDerm was founded in 1991 and is headquartered in Largo, United States. Proprietary hydrocolloid-based medical devices are developed for urinary management, security, infection control, and skin protection within the healthcare sector. Key offerings include Mens Liberty, a male external catheter suited for community-dwelling men, and Safe n Dry, intended for institutional and hospital settings. Leadership is provided by Chairman and CEO Gary Damkoehler.
BioDerm's top competitors include NanoVibronix and Aurie.
BioDerm offers Silverlon Dressings, Anasept Cleanser, and Men’s Liberty Device.
BioDerm has 2 investors. Key investors include Abacus Finance, and Mountaingate Capital.
Yes. BioDerm was acquired by Mountaingate in January 2021.